Sort by
Refine Your Search
-
. Experience in electrophysiology, however, is considered a particularly important strength.. The department of Molecular and Integrative Physiology (MIP) runs a structured professional development program for
-
and opportunity, U-M offers a comprehensive benefits package to help you stay well, protect yourself and your family, and plan for a secure future. Benefits include generous time off; retirement plan
-
Benefits at the University of Michigan The University of Michigan offers a comprehensive benefits package to help you stay well, protect yourself and your family, and plan for a secure future. For more
-
. Translational projects will require the postdoctoral fellow to work with faculty to plan study methods, draft IRB protocols, and carry out the project as detailed. It is essential that applicants have excellent
-
opportunity, U-M offers a comprehensive benefits package to help you stay well, protect yourself and your family, and plan for a secure future. Benefits include generous time off; retirement plan with two
-
applications. Our research program consists of two main thrusts, 1) the development and application of state-of-the-art laser and optical sensing techniques - both on the ground and in flight - to better
-
communication skills. Experience in coding with Python, MATLAB, Julia, C/C++, or a similar program language. Experience with biological data analysis. Knowledge of network science and/or complexity sciences
-
. Responsibilities* The successful candidate will be able to plan, develop, execute, and analyze an independent research project in the context of a supportive lab and institutional environment. In addition, they will
-
. Our faculty, staff, and trainees conduct a diverse range of musculoskeletal research and scholarship. The department?s research program is integral to its mission and vision of leading advances in
-
Apply Now Job Summary The Nucleic Acid Therapeutics Core is a newly initiated program at the University of Michigan to design and synthesize nucleic acid therapeutic molecules for early stage